Medytox’s Neuramis Clinches China Approval, Paving Way for Dermal Filler Market Entry
Medytox announced on the 25th that China’s National Medical Products Administration has granted product approval for its hyaluronic acid dermal...
Search results for "China product approval"
Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003
Rznomics, a biopharmaceutical company specializing in RNA-based gene therapies, announced on the 24th that it has received a decision to grant a U. S.
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
1
Powered by 